MANILA—AC Health and Glorious Dexa Mandaya Philippines, a subsidiary of Indonesia’s Dexa Group, are forming a strategic alliance aimed at strengthening the delivery of affordable, high-quality medicines for Filipinos.
The partnership will focus on the distribution of affordable medicines and other medical products developed by Dexa Group, leveraging AC Health’s integrated ecosystem—covering over 800 Generika and St. Joseph Drug stores, more than 220clinics and 6 hospitals under Healthway Medical Network, and the groups importation and distribution arm, IE Medica, which supports the introduction of new and relevant therapeutic solutions into the Philippines market.
“This partnership builds on our shared commitment to make healthcare more accessible, while continuing to raise the bar on quality,” said Paolo Borromeo, President and CEO of AC Health. “Dexa Group brings deep pharmaceutical expertise and a science-driven approach that complements AC Health’s expanding network of retail, provider, and specialty care assets. Together, we aim to serve more communities and deliver better value and outcomes for patients.”
The partnership also signals the creation of a joint project committee and the exploration of long-term synergies in distribution, wholesale, and innovation in health delivery across the country.
“More than a commercial collaboration, this is a convergence of purpose,” said Ferry Soetikno, CEO of Dexa Group. “By bringing together Dexa’s research capabilities with AC Health’s reach and mission-driven orientation, we are laying the groundwork for a more inclusive and future-ready healthcare system.”
Dexa Group is one of Indonesia’s largest pharmaceutical companies, known for its robust manufacturing capabilities, cutting-edge research and development, and evidence-based product lines across generics, oncology, and herbal medicine. Dexa Group develops clinically validated nutraceuticals and phytomedicines with global export potential. This partnership with AC Health marks Dexa’s first formal strategic collaboration in the Philippines—a significant step in its regional expansion.
“At the heart of this collaboration is our shared commitment to people,” said Atty. Yet Abarca, President and CEO of AC Health Pharma. “Through AC Health Pharma’s nationwide reach we have the privilege of serving millions of Filipinos every day. This partnership with the Dexa Group allows us to deepen that impact by expanding access to clinically backed, affordable medicines that respond to real needs in our communities.”
About AC Health
Established in 2015, AC Health has rapidly grown into one of the country’s most dynamic and integrated healthcare networks, driven by its vision to transform health for every Filipino.
AC Health operates across two core pillars—provider and pharma—creating a seamless healthcare ecosystem that addresses the full continuum of care. Its portfolio includes Healthway Medical Network, a network of multi-specialty clinics, ambulatory centers, and full-service hospitals; Generika Drugstore, the pioneer in generic retail pharmacies; IE Medica and MedEthix, a major pharmaceutical importer and distributor; and St. Joseph Drug, a leading retail pharmacy in North and Central Luzon.
Through its provider and pharma pillars, AC Health creates a seamless and integrated healthcare ecosystem for the Filipino patient.
About Dexa Group
Established in 1969, Dexa Group is a leading Indonesian pharmaceutical company founded on the principle of Expertise for the Promotion of Health. With over five decades of experience, Dexa develops and manufactures essential medicines, specialized therapies, and plant-based pharmaceutical products. Its manufacturing facilities are certified to meet international Good Manufacturing Practice(GMP) standards and are accredited by regulatory bodies such as Indonesia’s BPOM, the UK’s MHRA, and several EU-GMP certifications. The company also adopts Environmental, Social, and Governance (ESG) principles to ensure sustainable growth.
Media Contact: corporate.communications@dexagroup.com
